PREEMIEr Diagnostics Overview

  • Founded
  • 2020
Founded
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Latest Deal Amount
  • $25K
Latest Deal Amount
  • Investors
  • 1

PREEMIEr Diagnostics General Information

Description

Developer of a diagnostic device intended to measure blood glucose level in premature infants. The company's technology helps in identification of those premature infants who need an adjustment to their glucose levels, enabling doctors to detect and identify the onset of disease, thus help in improving the health of premature infants.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Diagnostic Equipment
Primary Office
  • Southfield, MI
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

PREEMIEr Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 22-Oct-2020 $25K Completed Startup
To view PREEMIEr Diagnostics’s complete valuation and funding history, request access »

PREEMIEr Diagnostics Executive Team (1)

Name Title Board Seat Contact Info
Tammy Movsas MD Founder
To view PREEMIEr Diagnostics’s complete executive team members history, request access »

PREEMIEr Diagnostics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
MassChallenge Accelerator/Incubator 000 0000 000000 0
To view PREEMIEr Diagnostics’s complete investors history, request access »